SIGA
SIGA Technologies Inc.
$6.52
+$0.27(+4.32%)
65
Overall
100
Value
41
Tech
55
Quality
Market Cap
$485.52M
Volume
257.50K
52W Range
$4.95 - $9.62
Target Price
$11.00
Company Overview
| Mkt Cap | $485.52M | Price | $6.52 |
| Volume | 257.50K | Change | +4.32% |
| P/E Ratio | 8.2 | Open | $6.30 |
| Revenue | $138.7M | Prev Close | $6.25 |
| Net Income | $59.2M | 52W Range | $4.95 - $9.62 |
| Div Yield | N/A | Target | $11.00 |
| Overall | 65 | Value | 100 |
| Quality | 55 | Technical | 41 |
No chart data available
About SIGA Technologies Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. The company's lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SIGA | $6.52 | +4.3% | 257.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |